Literature DB >> 20586611

Ectopic human mesenchymal stem cell-coated scaffolds in NOD/SCID mice: an in vivo model of the leukemia niche.

Sarah R Vaiselbuh1, Morris Edelman, Jeffrey M Lipton, Johnson M Liu.   

Abstract

Human mesenchymal stem cells form the supportive structure in which the functional cells of a differentiated tissue reside. We describe the creation of ectopic niches within polyurethane scaffolds coated with human mesenchymal stem cells. When implanted subcutaneously in NOD/SCID mice, these niches supported engraftment of primary human acute myeloid leukemia cells. The scaffolds showed vascularization and presence of osteoclasts and adipocytes, suggestive of an organizing human bone marrow microenvironment in the murine host. The chemokine stromal-derived factor-1 (SDF-1 or CXCL12) and its receptor CXCR4 are critical for homing and migration of acute myeloid leukemia. We found that a CXCR4 antagonist could disrupt homing to the ectopic niches, possibly by modulation of the mesenchymal stroma. We believe that these scaffold niches provide a new and powerful tool to study the leukemia stem cell microenvironment and may be useful for identification of novel drug targets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20586611     DOI: 10.1089/ten.tec.2010.0179

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  19 in total

Review 1.  A hostel for the hostile: the bone marrow niche in hematologic neoplasms.

Authors:  Daniela S Krause; David T Scadden
Journal:  Haematologica       Date:  2015-11       Impact factor: 9.941

2.  Versatile humanized niche model enables study of normal and malignant human hematopoiesis.

Authors:  Ander Abarrategi; Katie Foster; Ashley Hamilton; Syed A Mian; Diana Passaro; John Gribben; Ghulam Mufti; Dominique Bonnet
Journal:  J Clin Invest       Date:  2017-01-09       Impact factor: 14.808

3.  Modulation of stromal cell-derived factor-1/CXC chemokine receptor 4 axis enhances rhBMP-2-induced ectopic bone formation.

Authors:  Joel K Wise; Dale Rick Sumner; Amarjit S Virdi
Journal:  Tissue Eng Part A       Date:  2012-01-04       Impact factor: 3.845

Review 4.  Engineered Niches to Analyze Mechanisms of Metastasis and Guide Precision Medicine.

Authors:  Aaron H Morris; Sophia M Orbach; Grace G Bushnell; Robert S Oakes; Jacqueline S Jeruss; Lonnie D Shea
Journal:  Cancer Res       Date:  2020-05-14       Impact factor: 12.701

5.  Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment.

Authors:  Ye Chen; Rodrigo Jacamo; Yue-xi Shi; Rui-yu Wang; Venkata Lokesh Battula; Sergej Konoplev; Dirk Strunk; Nicole A Hofmann; Andreas Reinisch; Marina Konopleva; Michael Andreeff
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

Review 6.  Anti-Cancer Drug Validation: the Contribution of Tissue Engineered Models.

Authors:  Mariana R Carvalho; Daniela Lima; Rui L Reis; Joaquim M Oliveira; Vitor M Correlo
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

7.  A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells.

Authors:  Jlenia Guarnerio; Luisa Riccardi; Riccardo Taulli; Takahiro Maeda; Guocan Wang; Robin M Hobbs; Min Sup Song; Paolo Sportoletti; Rosa Bernardi; Roderick T Bronson; Mireia Castillo-Martin; Carlos Cordon-Cardo; Andrea Lunardi; Pier Paolo Pandolfi
Journal:  Cancer Discov       Date:  2015-01-22       Impact factor: 39.397

8.  A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cells.

Authors:  Omar S Aljitawi; Dandan Li; Yinghua Xiao; Da Zhang; Karthik Ramachandran; Lisa Stehno-Bittel; Peter Van Veldhuizen; Tara L Lin; Suman Kambhampati; Rama Garimella
Journal:  Leuk Lymphoma       Date:  2013-05-15

Review 9.  Engineering human hematopoietic environments through ossicle and bioreactor technologies exploitation.

Authors:  Pia Sommerkamp; François E Mercier; Adam C Wilkinson; Dominique Bonnet; Paul E Bourgine
Journal:  Exp Hematol       Date:  2020-12-02       Impact factor: 3.084

Review 10.  Stem cells and bone diseases: new tools, new perspective.

Authors:  Mara Riminucci; Cristina Remoli; Pamela G Robey; Paolo Bianco
Journal:  Bone       Date:  2014-09-18       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.